Literature DB >> 7842707

Tear concentrations of topically applied ciprofloxacin.

M Limberg1, C Buggé.   

Abstract

An open-label study of 20 normal, healthy volunteers was conducted to determine the tear concentrations after topical ocular application of ciprofloxacin 0.3% ophthalmic solution (Ciloxan). Tear samples were collected on Schirmer tear strips at 30 min, 2, 3, and 4 h, and were analyzed for ciprofloxacin using reverse-phase high-performance liquid chromatography. The results of this study showed the mean concentration, 4 h after dosing of ciprofloxacin, to be 16.0 micrograms/ml with 95% confidence limits of 8.15 and 23.79. It is concluded that concentrations of ciprofloxacin in tears were significantly greater than the minimum inhibitory concentrations for 90% of strains tested commonly reported for a majority of potential pathogens (i.e., < or = 2 micrograms/ml) 4 h after a single application of ciprofloxacin ophthalmic solution 0.3%.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7842707

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  4 in total

1.  Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998).

Authors:  S L Block; J Hedrick; R Tyler; A Smith; R Findlay; E Keegan; D W Stroman
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Drug formulations intended for the global market should be tested for stability under tropical climatic conditions.

Authors:  P G Risha; C Vervaet; G Vergote; L Van Bortel; J P Remon
Journal:  Eur J Clin Pharmacol       Date:  2003-04-30       Impact factor: 2.953

3.  Antimicrobial susceptibility and minimal inhibitory concentration of Pseudomonas aeruginosa isolated from septic ocular surface disease in different animal species.

Authors:  L Leigue; F Montiani-Ferreira; B A Moore
Journal:  Open Vet J       Date:  2016-11-15

4.  Alteration of TLR3 pathways by glucocorticoids may be responsible for immunosusceptibility of human corneal epithelial cells to viral infections.

Authors:  Yuko Hara; Atsushi Shiraishi; Takeshi Kobayashi; Yuko Kadota; Yuji Shirakata; Koji Hashimoto; Yuichi Ohashi
Journal:  Mol Vis       Date:  2009-05-08       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.